c-erbb growth-factor-receptor proteins in ovarian tumours

Autor: A M Lessells, B. J. B. Simpson, William R. Miller, Simon P. Langdon, Hamish A. Phillips
Rok vydání: 1995
Předmět:
Zdroj: International Journal of Cancer. 64:202-206
ISSN: 1097-0215
0020-7136
DOI: 10.1002/ijc.2910640310
Popis: Immunohistochemical expression of EGF-R, c-erbB-2 and c-erbB-3, members of the type-l family of receptor tyrosine kinases, were investigated in 67 primary ovarian-tumour samples (46 malignant, 8 borderline and 13 benign), and related to tumour clinicopathological features. The incidence of all 3 receptor proteins was highest in overtly malignant tumours. No significant correlations were observed between either EGF-R or c-erbB-3 and clinical parameters such as tumour stage, differentiation or extent of debulking surgery, but c-erbB-2 was significantly associated with several indicators of prognosis, including early stage and good/moderate differentiation in optimally debulked tumours. Multiple expression of c-erbB receptor proteins was also significantly higher in malignant tumours compared with borderline and benign tumours. Early-stage tumours were also more likely to express multiple c-erbB-receptor proteins than were late-stage tumours. Co-expression of EGF-R with c-erbB-2, and c-erbB-2 with c-erbB-3 was significantly greater in malignant tumours than in borderline or benign tumours, and within the malignant tumour group, positive associations were observed between EGF-R and c-erbB-3, also between c-erbB-2 and c-erbB-3. Because of the evidence of increased expression of individual c-erbB proteins as well as multiple expression of this family of growth-factor receptors in malignant ovarian tumours, we hypothesize that stimulation by the appropriate ligands may confer a selective advantage to cells expressing more than one receptor. Increased expression of c-erbB growth-factor receptors in malignancy may mediate increased propensity for tumour development. © 1995 Wiley-Liss, Inc.
Databáze: OpenAIRE
Externí odkaz: